|
 |
... -blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure ...
S Haas, T Vos, R Gilbert... - 52nd Annual Scientific ..., 2011 - , S., Vos, T., Gilbert, R. and Krum, H. (2003). Does the magnitude of the beneficial effect
of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A
meta-analysis of all-cause mortality outcomes from major chronic heart failure ...
Haas, S., Vos, T., Gilbert, R. and Krum, H. (2003). Does the magnitude of the beneficial effect of beta-blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure beta-blocker trials. In: , Journal of The American College of Cardiology: 52nd Annual Scientific Session of the American College of Cardiology. 52nd Annual Scientific Session of the American College of Cardiology, Chicago, Illinois, (163A-163A). 30- Mar 2 Apr 2003.
More Details:
... -blockers in chronic heart failure differ between diabetic and nondiabetic patients? A meta-analysis of all-cause mortality outcomes from major chronic heart failure ... |
|
|
